Publication Author: Basu_Anirban

• Is Maternal Income in Childhood Associated With Adolescent Health and Behavioral Outcomes?

  Shepherd-Banigan M, Basu A, Bell JF, Booth-LaForce C, Harris JR. Is Maternal Income in Childhood Associated With Adolescent Health and Behavioral Outcomes? J Fam Issues. 2019 May 1;40(7):911-928. doi: 10.1177/0192513×19829506. Epub 2019 Feb 19.

  rakerr2

  May 1, 2019

• Overview of Cost-effectiveness Analysis.

  Sanders GD, Maciejewski ML, Basu A. Overview of Cost-effectiveness Analysis. JAMA. 2019 Mar 11. doi: 10.1001/jama.2019.1265. [Epub ahead of print]

  rakerr2

  March 11, 2019

• How can clinical researchers quantify the value of their proposed comparative research?

  Basu A, Veenstra DL, Carlson JJ, Wang WJ, Branch K, Probstfield J. How can clinical researchers quantify the value of their proposed comparative research? Am Heart J. 2018 Dec 8. pii: S0002-8703(18)30337-5. doi: 10.1016/j.ahj.2018.12.003. [Epub ahead of p

  rakerr2

  March 1, 2019

• Choosing a Time Horizon in Cost and Cost-effectiveness Analyses.

  Basu A, Maciejewski ML. Choosing a Time Horizon in Cost and Cost-effectiveness Analyses. JAMA. 2019 Feb 21. doi: 10.1001/jama.2019.1153. [Epub ahead of print]

  rakerr2

  February 21, 2019

• Analysis of Benefit of Intensive Care Unit Transfer for Deteriorating Ward Patients: A Patient-Centered Approach to Clinical Evaluation.

  Grieve R, O’Neill S, Basu A, Keele L, Rowan KM, Harris S. Analysis of Benefit of Intensive Care Unit Transfer for Deteriorating Ward Patients: A Patient-Centered Approach to Clinical Evaluation. JAMA Netw Open. 2019 Feb 1;2(2):e187704. doi: 10.1001/jamane

  rakerr2

  February 1, 2019

• Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model.

  Basu A, Sohn MW, Bartle B, Chan KCG, Cooper JM, Huang E. Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model. Med Decis Making. 2019 Feb;39(2):137-151. doi: 10.1177/0272989X18817521. Epub 2019 Jan 17.

  rakerr2

  February 1, 2019

• Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials.

  Basu A, Prabhu VS, Dorr MB, Golan Y, Dubberke ER, Cornely OA, Heimann SM, Pedley A, Xu R, Hanson ME, Marcella S. Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinic

  rakerr2

  November 1, 2018

• Price elasticities of pharmaceuticals in a value based-formulary setting.

  Yeung K, Basu A, Hansen RN, Sullivan SD. Price elasticities of pharmaceuticals in a value based-formulary setting. Health Econ. 2018 Jul 20. doi: 10.1002/hec.3801. [Epub ahead of print]

  rakerr2

  November 1, 2018

• Comment: Manski’s views on patient care under uncertainty.

  Basu A. Comment: Manski’s views on patient care under uncertainty. Health Econ. 2018 Oct;27(10):1422-1424. doi: 10.1002/hec.3808. Epub 2018 Aug 2.

  rakerr2

  October 1, 2018

• Future Directions for Cost-effectiveness Analyses in Health and Medicine.

  Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, Sanders GD. Future Directions for Cost-effectiveness Analyses in Health and Medicine. Med

  rakerr2

  October 1, 2018